Recall Record

Los Angeles, CA, United States

Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls

1 recall recorded since 2018, most recently on 15 January 2020. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0

Terminated Class II, Class III Drugs

Recall started
15 January 2020
Terminated
7 December 2023
Reason
Lack of Assurance of Sterility
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Initiated
Voluntary: Firm initiated
Recall numbers
D-0960-2020, D-0937-2020, D-0943-2020, D-0971-2020, D-0981-2020, D-0940-2020, D-0953-2020, D-0936-2020, D-0955-2020, D-0965-2020, D-0991-2020, D-0975-2020 and 51 more

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.